The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
147 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $52,864,503 in first-year total cost, median $417,853.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BDCN-A (55)]18
- Chronic Dysfunction and Integrative Neurodegeneration Study Section[CDIN]11
- Clinical Neuroscience and Neurodegeneration Study Section[CNN]10
- Special Emphasis Panel[ZRG1 MDCN-P (56)]10
- Cellular and Molecular Biology of Glia Study Section[CMBG]7
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL7
- COLUMBIA UNIVERSITY HEALTH SCIENCES6
- UNIVERSITY OF CALIFORNIA, SAN DIEGO6
- UNIVERSITY OF WISCONSIN-MADISON6
- UNIVERSITY OF CALIFORNIA-IRVINE5
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Alternative folding of soluble proteins induced by Aβ42 and Tau in aged cells1R21AG077556-01 | ZHOU, CHUANKAI | BUCK INSTITUTE FOR RESEARCH ON AGING, CA | $533,500 | CMAD |
| 2022 | Reducing cognitive decline in patients with mild cognitive impairment and Alzheimer's Disease and related dementias by developing and testing clinician and caregiver deprescribing tools1R21AG075928-01 | LAUFFENBURGER, JULIE CHRISTINE | BRIGHAM AND WOMEN'S HOSPITAL, MA | $510,979 | ODHS |
| 2022 | Mapping tauopathy-induced changes in subcellular proteostasis with compartment-targeted sensors1R21AG079267-01 | DEMONTIS, FABIO | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $500,500 | CMAD |
| 2022 | Identifying risk factors of Alzheimer's disease and related dementias in older Chinese immigrants1R21AG077649-01 | LI, CLARA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $495,123 | APDA |
| 2022 | Functional and Transcriptional Profiling of Monocytes in Alzheimer's Disease1R21AG072486-01A1 | WEINER, HOWARD L | BRIGHAM AND WOMEN'S HOSPITAL, MA | $492,250 | ZRG1 |
| 2022 | Endothelial Pannexin1 in Alzheimer’s Disease1R21AG075796-01A1 | GOOD, MIRANDA E | TUFTS MEDICAL CENTER, MA | $489,500 | BINP |
| 2022 | Multimodal imaging measures to assess synaptic dysfunction in Alzheimer's disease1R21AG077498-01 | RANASINGHE, KAMALINI GAYATHREE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $483,995 | ZRG1 |
| 2022 | Home Based Primary Care for Persons Living with Dementia: Nurse Practitioner Teams and Outcomes1R21AG077384-01 | OSAKWE, ZAINAB TOTEHPOGHOSYAN, LUSINE | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $476,847 | ZRG1 |
| 2022 | Selective neurovascular regulation by a vascular dementia-related noncoding RNA Snord1181R21AG070681-01A1 | CHEN, JIANFU | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $467,471 | ZRG1 |
| 2022 | Digital Spatial Profiling of Hippocampal Subregions in Alzheimer’s Disease, Primary Age-Related Tauopathy, and Chronic Traumatic Encephalopathy1R21AG078505-01 | RICHARDSON, TIMOTHY ERICWALKER, JAMIE | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $464,750 | CNN |
| 2022 | Shedding light on functional heterogeneity of dementia-related alpha-synuclein strains1R21AG077631-01 | LIANG, YAJIE | UNIVERSITY OF MARYLAND BALTIMORE, MD | $463,124 | CMND |
| 2022 | Leveraging simultaneous BOLD-fMRI and wide-field Ca2+ imaging to reveal measures of neurovascular health that cross scales and species which have AD symptom and treatment response prognostic utility1R21AG075778-01 | LAKE, EVELYN MR | YALE UNIVERSITY, CT | $460,625 | CDIN |
| 2022 | Generation and trans-neuronal seeding of phosphorylated T217-Tau in aging macaque cortical circuits1R21AG079145-01 | DATTA, DIBYADEEP | YALE UNIVERSITY, CT | $460,625 | CDIN |
| 2022 | Integrative analysis of proteomics and transcriptomics to delineate vesicular transport related protein abnormalities related to Alzheimer's, Lewy body and mixed Pathologies1R21AG074287-01A1 | BEBEK, GURKANPILLAI, JAGAN AYYAPPAN | CLEVELAND CLINIC LERNER COM-CWRU, OH | $455,583 | ZRG1 |
| 2022 | Neurovascular functions of a small RNA Snord118-mediated ribosome biogenesis1R21AG075665-01 | CHEN, JIANFU | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $453,750 | BINP |
| 2022 | Dynamic immune cell landscape in late-onset Alzheimer's disease: role of ApoE-mediated microglial lipid metabolism1R21AG070971-01A1 | YU, I-CHEN IVORINE | INDIANA UNIVERSITY INDIANAPOLIS, IN | $451,042 | CMBG |
| 2022 | MRI assessment of cerebral oxygen extraction fraction (OEF) in the medial temporal lobe as a biomarker in Alzheimer's disease1R21AG079098-01 | LU, HANZHANG | JOHNS HOPKINS UNIVERSITY, MD | $450,313 | EITN |
| 2022 | Validating pig models for Alzheimer's disease1R21AG079292-01 | ALLEN, TIMOTHY ALEXANDERJAROME, TIMOTHY JOSEPHLEE, KIHO | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $446,615 | CDIN |
| 2022 | Development and evaluation of cell therapy strategies for Alzheimer's disease.1R21AG075807-01A1 | KASTANENKA, KSENIA V. | MASSACHUSETTS GENERAL HOSPITAL, MA | $445,680 | ZRG1 |
| 2022 | Identifying shared and distinct cell type vulnerability across neurological diseases.1R21AG075754-01 | AL DALAHMAH, OSAMAGOLDMAN, JAMESMENON, VILAS | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $445,500 | MNG |
| 2022 | Human Astrocyte-Based Nanovesicles to Target Neuroinflammation in Alzheimer's Disease1R21AG075189-01 | KRENCIK, ROBERT CONRADTARABALLI, FRANCESCA | METHODIST HOSPITAL RESEARCH INSTITUTE, TX | $444,125 | BNVT |
| 2022 | Genetic risk for trajectories of cognitive decline and progression to dementia among Mexican Americans and non-Hispanic whites1R21AG075791-01A1 | JIAN, XUEQIU | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $439,550 | ZRG1 |
| 2022 | Common CD36-dependent gut-brain neuroimmune pathway regulates disruption of intestinal motility in Alzheimer's Disease1R21AG077521-01 | BECKER, LARENSHAMLOO, MEHRDAD | STANFORD UNIVERSITY, CA | $437,265 | ZRG1 |
| 2022 | Protein homeostasis in a frontotemporal dementia iPSC model1R21AG075814-01A1 | CHU, CHARLEEN T | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $434,890 | CMND |
| 2022 | Microbial dysbiosis as a driver of neuroinflammation and pathology in Alzheimer's disease1R21AG075836-01 | LUKENS, JOHN R | UNIVERSITY OF VIRGINIA, VA | $434,655 | ZRG1 |
| 2022 | Arachnoid Granulation Senescence in Aging, CAA and Alzheimer's Disease1R21AG079221-01 | MEHTA, RUPAL I. | RUSH UNIVERSITY MEDICAL CENTER, IL | $434,500 | ZRG1 |
| 2022 | Synthetically-evolved and engineered Nanobodies selective for Cb isoforms of PKA1R21AG079330-01 | CHANG, GEOFFREY ATAYLOR, SUSAN S. | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $434,500 | EBIT |
| 2022 | Optimization of imaging mass cytometry, a single-cell spatial proteomics technology, for the study of Alzheimer disease1R21AG077643-01 | XU, JINBINZHAO, GUOYAN | WASHINGTON UNIVERSITY, MO | $433,125 | EBIT |
| 2022 | Evaluation of Monoamine Oxidase-A as a New Biomarker for Alzheimer's Disease1R21AG079189-01 | MUKHERJEE, JOGESHWAR | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $431,750 | CNN |
| 2022 | Establishing Genotype-to-Phenotype Relationships Between Alzheimer’s Related BIN1 Variants1R21AG079279-01 | BRAFMAN, DAVID A | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $431,750 | ZRG1 |
| 2022 | PET imaging for neuroimmune function in Alzheimer's disease1R21AG078058-01 | LIANG, STEVEN H | EMORY UNIVERSITY, GA | $430,375 | EITN |
| 2022 | Development of the ADRD Systematic Hospital Inclusion Family Toolkit: A-SHIFT1R21AG077439-01 | FIELDS, BETHWERNER, NICOLE E | TRUSTEES OF INDIANA UNIVERSITY, IN | $428,925 | ZRG1 |
| 2022 | Characterizing the Effect of Altered CSF and Blood Flow Dynamics on Alzheimer’s Disease Proteinopathy, Brain Health, and Cognition1R21AG077337-01 | RIVERA RIVERA, LEONARDO A | UNIVERSITY OF WISCONSIN-MADISON, WI | $427,625 | CNN |
| 2022 | Development and characterization of EEG signature of cognitive fluctuations in Lewy body dementia1R21AG077469-01 | BARRETT, MATTHEW JAMESMUKHOPADHYAY, NITAI D. | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $426,938 | ZRG1 |
| 2022 | Protein Stability Profiling for the Characterization of Alzheimer's Disease1R21AG074317-01A1 | FITZGERALD, MICHAEL C | DUKE UNIVERSITY, NC | $423,898 | ZRG1 |
| 2022 | Oxidative stress-induced vascular pathology and dysfunction in Alzheimer’s disease1R21AG074146-01A1 | SOMPOL, PRADOLDEJ | UNIVERSITY OF KENTUCKY, KY | $420,750 | ZRG1 |
| 2022 | Roles of neuroestradiol in comorbid hyperexcitability and seizure susceptibility in Alzheimer Disease1R21AG077694-01 | CHRISTIAN-HINMAN, CATHERINE A | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $417,878 | ZRG1 |
| 2022 | Predicting glymphatic function via PET/MR imaging biomarkers and Nose to Brain contrast delivery1R21AG075795-01 | ZINN, KURT R | MICHIGAN STATE UNIVERSITY, MI | $417,853 | EITN |
| 2022 | Investigating the cause of cerebral blood flow reductions in a mouse model of frontotemporal dementia1R21AG075798-01A1 | BRACKO, OLIVER | UNIVERSITY OF MIAMI CORAL GABLES, FL | $410,845 | BINP |
| 2022 | Identification of endophenotypes associated with Alzheimer’s disease progression in Hispanic population1R21AG077501-01 | ALMEIDA, MARCIO | UNIVERSITY OF TEXAS RIO GRANDE VALLEY, TX | $404,953 | ZRG1 |
| 2022 | Proteomic aging clock and brain structure, cognitive decline and the risk of Alzheimers Disease and related dementias1R21AG079242-01 | PRIZMENT, ANNASEDAGHAT, SANAZ | UNIVERSITY OF MINNESOTA, MN | $400,146 | ZRG1 |
| 2022 | Digital biomarkers for Alzheimer's Disease with compact dual-mode brain sensing1R21AG079309-01 | LIU, HANLI | UNIVERSITY OF TEXAS ARLINGTON, TX | $388,494 | ZRG1 |
| 2022 | Post-mortem MRI for improving the diagnosis of Alzheimer’s mimics in the oldest old1R21AG075870-01 | SAJJADI, SEYED AHMAD | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $251,801 | CNN |
| 2022 | Recruiting multiethnic populations to preclinical Alzheimers disease trials1R21AG074371-01A1 | GRILL, JOSHUA | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $250,219 | HHD |
| 2022 | Blood DNA Methylation Biomarkers of Alzheimer’s Disease and Postoperative Neurocognitive Disorder1R21AG077633-01 | ALISCH, REID SPENCERHOGAN, KIRK J | UNIVERSITY OF WISCONSIN-MADISON, WI | $249,590 | ZRG1 |
| 2022 | CCN1-induced Senescence in the Cerebral Vasculature1R21AG075750-01 | MORUNO MANCHON, JOSE FELIX | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $234,000 | BINP |
| 2022 | Bioengineering a cortical microtissue model to study human microglia in Alzheimer's disease1R21AG077697-01 | BORTON, DAVID ALLENSONHUANG, YU-WEN ALVIN | BROWN UNIVERSITY, RI | $226,793 | CMBG |
| 2022 | Feasibility of Linking the Occupational Exposome to Alzheimer's Disease Neuropathology1R21AG079277-01 | POWELL, WILLIAM RYAN | UNIVERSITY OF WISCONSIN-MADISON, WI | $226,590 | ZRG1 |
| 2022 | Multimorbidity Trajectories, Psychosocial Resilience and Stress, and Risk of Dementia and Poor Cognitive Functioning1R21AG079233-01 | WHILBY, KELLEE WHITE | UNIV OF MARYLAND, COLLEGE PARK, MD | $226,081 | SSPB |
| 2022 | Phase separation of nuclear tau and its role in gene regulation1R21AG079239-01 | DEBELOUCHINA, GALIA | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $224,864 | MSFC |
| 2022 | Engaging care partners in fall risk management for community-dwelling older adults living with dementia1R21AG079316-01 | ZHOU, YUANJIN | UNIVERSITY OF TEXAS AT AUSTIN, TX | $209,540 | CIHB |
| 2022 | Mapping protein interactome of TREM2 and its variants to probe the etiology of Alzheimer's Disease1R21AG075875-01 | GAO, JIE | OHIO STATE UNIVERSITY, OH | $196,875 | ZRG1 |
| 2021 | New assay method for pinpointing structural features in amyloid oligomer formation1R21AG072478-01 | RALSTON, CORIE Y | UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB, CA | $558,671 | MSFB |
| 2021 | Defining Molecular Signatures Underlying Lysosomal Dysfunction in Alzheimer’s Disease1R21AG072511-01 | WEISSMAN, JONATHAN S. | WHITEHEAD INSTITUTE FOR BIOMEDICAL RES, MA | $536,250 | CMND |
| 2021 | Targeting conserved diet-responsive transcriptional networks in neurons to slow neurodegeneration in Alzheimer's disease1R21AG072663-01 | KAPAHI, PANKAJ | BUCK INSTITUTE FOR RESEARCH ON AGING, CA | $533,500 | NOMD |
| 2021 | Identifying Risk Factors For Late-Life Dementia Based On Job Characteristics During The Working Life1R21AG072609-01 | HUDOMIET, PETER | RAND CORPORATION, CA | $528,653 | SSPA |
| 2021 | Nuclear transport as a molecular and cellular vulnerability in AD1R21AG072516-01 | MITCHISON, TIMOTHY JSONG, YUYU | HARVARD MEDICAL SCHOOL, MA | $480,625 | SYN |
| 2021 | Microvascular Network Degeneration in a Novel Mouse Model of Alzheimer's Disease and Cerebral Amyloid Angiopathy1R21AG070859-01 | SCHRAG, MATTHEW | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $466,590 | CNN |
| 2021 | Development and validation of a law-cost cerebral oximeter for detection of cognitive impairment and Alzheimer's disease1R21AG072481-01 | FRANCESCHINI, MARIA ANGELASALAT, DAVID H | MASSACHUSETTS GENERAL HOSPITAL, MA | $462,000 | ZRG1 |
| 2021 | Muli-scale Structural Imaging of Alzheimer's Disease Neuropathology and Neurodegeneration1R21AG072431-01 | DICKERSON, BRADFORD CSALAT, DAVID H | MASSACHUSETTS GENERAL HOSPITAL, MA | $461,108 | CNN |
| 2021 | Development of Retinal Biomarkers in Autosomal Dominant Alzheimer's Disease: A pilot study1R21AG074153-01 | ALBER, JESSICA | UNIVERSITY OF RHODE ISLAND, RI | $458,896 | CNN |
| 2021 | Glial lactate and sleep-wake disturbances of Alzheimer's disease1R21AG070927-01 | HAYDON, PHILIP G | TUFTS UNIVERSITY BOSTON, MA | $453,750 | CDIN |
| 2021 | Phosphorylated tau protein detection in olfactory neurons at a single-cell resolution: needle-free biopsy for Alzheimer's disease pathophysiology study1R21AG070754-01 | ISHIZUKA, KOKO | JOHNS HOPKINS UNIVERSITY, MD | $450,313 | ZRG1 |
| 2021 | A multidimensional approach to studying the impact of caregiving on health among dementia caregivers1R21AG072395-01 | CHO, JINMYOUNG | BAYLOR RESEARCH INSTITUTE, TX | $445,288 | CMPC |
| 2021 | Factors Associated with Healthcare Utilization Among Community-Dwelling Adults with Clinical Features of Dementia with Lewy Bodies1R21AG074368-01 | WYMAN-CHICK, KATHRYN A | HEALTHPARTNERS INSTITUTE, MN | $440,890 | ODHS |
| 2021 | CareBand: A Collaborative Pilot Study to Optimize a Life-Space Performance Metric for Monitoring and Early Detection of Alzheimer's Disease and Related Dementias in Rural and Indigenous Communities1R21AG072566-01 | WARRY, WAYNE RICHARD | UNIVERSITY OF MINNESOTA, MN | $438,699 | ZRG1 |
| 2021 | Stricker Learning Span: A Computer Adaptive Word List Memory Test Optimized for Remote Assessment1R21AG073967-01 | STRICKER, NIKKI H | MAYO CLINIC ROCHESTER, MN | $437,250 | APDA |
| 2021 | Magnetic susceptibility and volume of microvascular lesions as proof-of concept biomarkers for mixed dementia1R21AG069477-01A1 | CHENG, YU-CHUNG NORMANCOUNTS, SCOTT E | WAYNE STATE UNIVERSITY, MI | $437,221 | EITA |
| 2021 | ABCA7 dysfunction in Alzheimer's disease pathogenesis1R21AG069180-01A1 | ALAM, AMER | UNIVERSITY OF MINNESOTA, MN | $435,750 | BPNS |
| 2021 | The Role of Chromogranin A in Tauopathy1R21AG072487-01 | CHEN, XUGHOSH, GOURISANKARMAHATA, SUSHIL K | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $434,375 | ZRG1 |
| 2021 | Enhancing microglia-dependent plaque clearance in the Alzheimer disease brain by targeting Ifi27l2a expression1R21AG072488-01 | KIM, GAB SEOK | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $428,984 | ZRG1 |
| 2021 | Investigating CD33 function on microglia during Alzheimer’s disease using CRISPR nanoparticles1R21AG072423-01 | HOPP, SARAH CHRISTINE | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $425,625 | CMBG |
| 2021 | Empathy, Support Exchanges, and Well-Being in Older Couples Coping With Early Stage Alzheimer’s Disease1R21AG069045-01A1 | HUO, MENG | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $424,269 | SPIP |
| 2021 | Gene Profile Analysis of Associations between Alzheimer’s Disease and Circadian Rhythmic Patterns of Human Brain Regions Using Machine Learning1R21AG070909-01 | CHENG, QIANG | UNIVERSITY OF KENTUCKY, KY | $420,750 | ZRG1 |
| 2021 | Disease Mechanisms at the Intersection of Glaucoma and Alzheimer's Disease1R21AG074395-01 | MCLELLAN, GILLIAN JANE | UNIVERSITY OF WISCONSIN-MADISON, WI | $414,306 | ZRG1 |
| 2021 | Exploring the Use of Deep Learning Neural Networks to Improve Dementia Detection: Automating Coding of the Clock-Drawing Test1R21AG073971-01 | HU, MENGYAO | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $406,555 | NAME |
| 2021 | Uncovering BIN1 functions in myelin-producing oligodendrocytes1R21AG072479-01 | LI, JIANRONG | TEXAS A&M UNIVERSITY, TX | $402,526 | CMBG |
| 2021 | Study of Comorbid Seizures in Alzheimer's Disease1R21AG071278-01 | TSAI, NIEN-PEI | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $401,252 | NTRC |
| 2021 | Smartphone Pupillometer for At-Home Screening for Risk of Alzheimer’s Disease1R21AG072534-01 | WANG, EDWARD JAY | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $392,099 | ZRG1 |
| 2021 | Leukocyte Telomere Length, Mitochondrial DNA Copy Number, Plasma Proteomics, and Alzheimer's Disease-related Dementia1R21AG072530-01 | TANG, WEIHONG | UNIVERSITY OF MINNESOTA, MN | $385,204 | BGES |
| 2021 | MALDI imaging of glial scar-forming glycans in Alzheimers disease1R21AG074152-01 | ALONGE, KIMBERLY MICHELE | UNIVERSITY OF WASHINGTON, WA | $264,750 | ZRG1 |
| 2021 | Engineering Human Brain Neurovascular Niche for Modeling Brain Diseases1R21AG074373-01 | YOUNG, JESSICA ELAINEZHENG, YING | UNIVERSITY OF WASHINGTON, WA | $264,750 | ZRG1 |
| 2021 | Elevated locus coeruleus metabolism as mechanism driving Alzheimer's disease pathology1R21AG074220-01 | JACOBS, HEIDI IRMA | MASSACHUSETTS GENERAL HOSPITAL, MA | $260,146 | ZRG1 |
| 2021 | Alterations in Ventral Hippocampal CA1 Processing as a Mechanism for Anxiety in Alzheimer’s Disease1R21AG070880-01 | MASURKAR, ARJUN VIJAY | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $254,250 | ZRG1 |
| 2021 | Novel Spectral Biomarkers for Alzheimer's Disease1R21AG070972-01 | MCMURRAY, CYNTHIA THERESE | UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB, CA | $252,345 | ZRG1 |
| 2021 | Validation of a Virtual Reality Floor Maze Test to Detect Early Signs of Cognitive Impairment1R21AG072469-01 | MARTELLI, DARIO | UNIVERSITY OF ALABAMA IN TUSCALOOSA, AL | $248,407 | CP |
| 2021 | PET Imaging for neuroinflammation in Alzheimer's disease1R21AG074218-01 | LIANG, STEVEN H | MASSACHUSETTS GENERAL HOSPITAL, MA | $246,560 | CNN |
| 2021 | Combining information from multiple circadian activity rhythm metrics to optimally detect mild cognitive impairment using a consumer wearable1R21AG074094-01 | SMAGULA, STEPHEN F | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $245,140 | APDA |
| 2021 | Immunoprofiling postoperative delirium during aging and neurodegeneration1R21AG074232-01 | GELBARD, HARRIS ATERRANDO, NICCOLO | UNIVERSITY OF ROCHESTER, NY | $239,843 | CDIN |
| 2021 | Infectious Influence: Using fate mapping to determine the impact of viral infection sites on Alzheimer's disease initiation1R21AG074324-01 | MOSEMAN, E. ASHLEY | DUKE UNIVERSITY, NC | $237,829 | ZRG1 |
| 2021 | Identification of intrinsic and extrinsic regulators of TDP43 splicing function1R21AG070619-01 | ROHATGI, RAJAT | STANFORD UNIVERSITY, CA | $236,288 | MNG |
| 2021 | Characterization of Orexin/Hypocretin Kinetics in Alzheimer's Disease1R21AG074151-01 | LUCEY, BRENDAN PATRICK | WASHINGTON UNIVERSITY, MO | $236,250 | CNN |
| 2021 | Interplay between amyloid precursor protein metabolism and ER-mitochondria contact1R21AG074414-01 | LU, BINGWEI | STANFORD UNIVERSITY, CA | $236,100 | MBPP |
| 2021 | The role of NMDA receptor subunit GluN3A in age and Alzheimer's disease-related dementia1R21AG067473-01A1 | YU, SHAN P. | EMORY UNIVERSITY, GA | $234,750 | NOMD |
| 2021 | Cost effective Electroencephalography sensor for monitoring sleep disruption in early stages of Alzheimer's disease1R21AG072517-01 | WU, JIAN-YOUNG | GEORGETOWN UNIVERSITY, DC | $234,000 | ZRG1 |
| 2021 | Synergistic effect of APOE genotype and obesity in CNS inflammation and risk of Alzheimer's disease1R21AG074139-01 | REBECK, G WILLIAM | GEORGETOWN UNIVERSITY, DC | $234,000 | CDIN |
| 2021 | Drug Discovery for Alzheimer’s Disease Enabled by Multi-Omics and Artificial Intelligence1R21AG074234-01 | MEYER, JESSE | MEDICAL COLLEGE OF WISCONSIN, WI | $234,000 | MNG |
| 2021 | Sexual Dimorphism in Cerebral Amyloid Angiopathy and Vascular Dementia: Investigating the Role of Fibrinolytic System1R21AG070860-01A1 | MANWANI, BHARTI | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $234,000 | CDIN |
| 2021 | Deciphering the non-canonical function of the histone methyltransferase G9a in the etiology of AD1R21AG071229-01 | CHEN, XIAN | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $233,250 | MNG |
| 2021 | Altered Diversity of Astrocyte sub-types and Signaling Capabilities in Alzheimer's Disease1R21AG074293-01 | ASRICAN, BRENT | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $233,250 | CMBG |
| 2021 | Validation of the DCTclock drawing task as a cognitive screening tool for prodromal Alzheimers disease in the Framingham Heart Study1R21AG072588-01 | THOMPSON, LOUISA | BROWN UNIVERSITY, RI | $231,533 | CP |
| 2021 | Development of in vivo quantitative stable isotope probing to quantify microbiome dynamics in Alzheimers Disease1R21AG074203-01 | COPE, EMILY K | NORTHERN ARIZONA UNIVERSITY, AZ | $228,000 | CDIN |
| 2021 | Understanding the relationship between female reproductive span and dementia risk1R21AG074212-01 | PANIZZON, MATTHEW S | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $226,840 | NAME |
| 2021 | Linked Lives, Linked Health: Health Trajectories of Persons with Cognitive Impairment and Their Caregivers' Health1R21AG074238-01 | ZANG, EMMA | YALE UNIVERSITY, CT | $223,942 | SSPA |
| 2021 | How Distinct are the two Chiral Sulfur Epimers of Amyloid Beta Met35 Sulfoxide in their Aggregation, Toxicity and Reactivity with Methionine Sulfoxide Reductases A and B?1R21AG070888-01 | RASKATOV, JEVGENIJ | UNIVERSITY OF CALIFORNIA SANTA CRUZ, CA | $222,329 | MSFA |
| 2021 | The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People with Dementia1R21AG070942-01 | SACARNY, ADAM JON | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $217,583 | HSOD |
| 2021 | Investigating the Effects of APOE Genotype on AD Pathology in a Novel AD Mouse Model1R21AG074308-01 | GUO, JIANURIEL, TAL | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $202,500 | CDIN |
| 2021 | Multiclass classification under prioritized error control and specific error costs with applications to dementia classification1R21AG074205-01 | FENG, YANG | NEW YORK UNIVERSITY, NY | $199,405 | BMRD |
| 2021 | The Role of COVID-19 Endothelial Cell Dysfunction and Hypercoagulability in the Development of Post-ICU Cognitive Impairment and Dementia1R21AG074179-01 | WANG, SOPHIA | INDIANA UNIVERSITY INDIANAPOLIS, IN | $198,125 | ZRG1 |
| 2021 | Preventing Alzheimer's Disease with Designer Lipids1R21AG074331-01 | SCOTT, ALISON J | UNIVERSITY OF MARYLAND BALTIMORE, MD | $193,125 | ZRG1 |
| 2021 | Social spatial navigation assessment for early-stage Alzheimer's disease1R21AG070877-01 | ARZY, SHAHARMARSHALL, GAD ASHERSPIERS, HUGO | BRIGHAM AND WOMEN'S HOSPITAL, MA | $190,054 | APDA |
| 2021 | Neuroimage-driven biophysical inverse problems for atrophy and tau propagation1R21AG074276-01 | BIROS, GEORGE | UNIVERSITY OF TEXAS AT AUSTIN, TX | $183,464 | ZRG1 |
| 2021 | Helping the helpers: User-centered technology to aid caregiver management of medications for people with ADRD1R21AG072418-01 | HOLDEN, RICHARD JWERNER, NICOLE E | UNIVERSITY OF WISCONSIN-MADISON, WI | $148,650 | CMPC |
| 2021 | Development of an Intervention for Long-Distance Caregivers1R21AG069019-01A1 | CIMAROLLI, VERENA | LEADINGAGE, INC., DC | $141,024 | SPIP |
| 2021 | Targeting Whole-body Fatty Acid Metabolism in Alzheimer’s Disease, with Special Interest in Lauric acid1R21AG072561-01 | GU, HAIWEIJENTARRA, GARILYN MARIE | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $1 | ZRG1 |
| 2020 | Evolving CRISPR-based platforms for the discovery of Alzheimer relevant neurodegenerative pathways1R21AG069183-01 | MUCKE, LENNART | J. DAVID GLADSTONE INSTITUTES, CA | $519,750 | ZRG1 |
| 2020 | Determining neuroprotective autophagy functions using different types of human neurons1R21AG067570-01 | YANG, NANYUE, ZHENYU | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $466,125 | CMND |
| 2020 | Exploring the Relationship Between Tau Deposition and Neurovascular Health in Alzheimer's Disease1R21AG067562-01 | HUANG, SUSIE YIYEN, YI-FEN | MASSACHUSETTS GENERAL HOSPITAL, MA | $462,000 | ZRG1 |
| 2020 | Correction of Partial Volume Effects in PET for Alzheimer's Disease Using Unsupervised Deep Learning1R21AG067422-01 | GONG, KUANG | MASSACHUSETTS GENERAL HOSPITAL, MA | $452,956 | EITA |
| 2020 | Brain microbial proteome in normal aging and Alzheimer's disease1R21AG067400-01 | VEGA, IRVING E | MICHIGAN STATE UNIVERSITY, MI | $444,134 | ZRG1 |
| 2020 | A Novel Animal Model of Late Onset Alzheimer's Disease1R21AG067340-01 | GOTTSCHALK, WILLIAM KIRBY | DUKE UNIVERSITY, NC | $442,750 | CDIN |
| 2020 | Hyper phosphorylation and the plexin CRMP scaffold in Alzheimers Disease1R21AG069268-01 | BUCK, MATTHIAS | CASE WESTERN RESERVE UNIVERSITY, OH | $442,750 | BPNS |
| 2020 | tRNA-derived RNA Fragments, A New Regulator for Alzheimer's Disease1R21AG069226-01 | BAO, XIAOYONG | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $434,500 | ZRG1 |
| 2020 | Characterization of Neurofilament Light Chain in Alzheimer's Disease and Other Neurodegenerative Disorders1R21AG067559-01 | BATEMAN, RANDALL J | WASHINGTON UNIVERSITY, MO | $432,938 | ZRG1 |
| 2020 | NF-κB as a driver of neurotoxic astrocytes in Alzheimers disease1R21AG069081-01 | LAFERLA, FRANK M | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $431,750 | CMBG |
| 2020 | Regulation of microglia by tissue stiffness and Piezo1 in Alzheimer's disease1R21AG069067-01 | LIU, WENDY | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $431,750 | CMBG |
| 2020 | Personalized predictions of biomarker progression in Alzheimer's disease1R21AG067442-01 | WEICKENMEIER, JOHANNES | THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY, NJ | $424,050 | CNN |
| 2020 | Involvement of an ER to lysosome signaling axis in the onset of neurodegeneration in models of AD1R21AG067414-01 | VENKATACHALAM, KARTIK | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $421,329 | SYN |
| 2020 | Understanding the influence of FTDP-17 mutation on human tau circular RNA formation and function to develop treatment options1R21AG067438-01 | STAMM, STEFAN | UNIVERSITY OF KENTUCKY, KY | $420,750 | CMND |
| 2020 | Branched-chain amino acids as a novel biomarker and treatment for Alzheimer's disease1R21AG069140-01 | HEGDE, VIJAY KARKALSHIN, ANDREW CHANGHUN | TEXAS TECH UNIVERSITY, TX | $415,355 | ZRG1 |
| 2020 | Structural transformations of dementia-related proteins: droplets, gels and amyloids1R21AG069064-01 | DEBELOUCHINA, GALIA | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $413,431 | MSFB |
| 2020 | Genetic analysis of mitochondria-dependent cellular toxicity of alpha-synuclein1R21AG067446-01 | ZHONG, QUAN | WRIGHT STATE UNIVERSITY, OH | $412,500 | CMAD |
| 2020 | Ceramide Signaling in AD Pathogenesis1R21AG067443-01 | BHAT, NARAYAN R | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $411,125 | ZRG1 |
| 2020 | Development of in vitro disease-relevant strains of tau1R21AG069112-01 | GAMBLIN, TRUMAN C | UNIVERSITY OF TEXAS SAN ANTONIO, TX | $404,500 | BPNS |
| 2020 | Identifying Metabolomic Risk Factors in Plasma and Cerebrospinal Fluid for Alzheimer's Disease1R21AG067092-01 | LU, QIONGSHI | UNIVERSITY OF WISCONSIN-MADISON, WI | $374,959 | ZRG1 |
| 2020 | Pregnancy complications and the development of Alzheimer's disease and related dementias in women in the Adult Changes in Thought study1R21AG069111-01 | MILLER, ELIZA C | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $316,973 | ZRG1 |
| 2020 | Role of Senescent T cells in Alzheimer's Disease1R21AG067441-01 | PENG, GUANGYONG | SAINT LOUIS UNIVERSITY, MO | $285,918 | ZRG1 |
| 2020 | Validation of The Environmental Audit Scoring Evaluation (EASE) Tool1R21AG067010-01 | KAUP, MIGETTE | KANSAS STATE UNIVERSITY, KS | $246,388 | CIHB |
| 2020 | Modulation of TGF-beta signaling by omega-6 polyunsaturated fatty acids for treating Alzheimer's disease1R21AG069100-01 | MA, QIULAN | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $234,000 | ZRG1 |
| 2020 | The Effects of Cognitive Map Building on the Development of Alzheimer's Disease1R21AG069267-01 | KENNEDY, KRISTEN M.YUAN, MAY | UNIVERSITY OF TEXAS DALLAS, TX | $229,500 | NAME |
| 2020 | Cellular Mechanism underlying emotional problems of Alzheimer's disease1R21AG067445-01 | LIU, MENG | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $224,250 | ZRG1 |
| 2020 | Functional assessment of 1,500 human genes against coexistent Abeta and tau pathology in vivo1R21AG069050-01 | RINCON-LIMAS, DIEGO E | UNIVERSITY OF FLORIDA, FL | $221,586 | CMND |
| 2020 | Refining a Driving Cessation Management Intervention for Person with Dementia and their Family Caregivers: CarFreeMe1R21AG067537-01 | GAUGLER, JOSEPH E. | UNIVERSITY OF MINNESOTA, MN | $195,033 | APDA |
| 2019 | The molecular mechanism of PICALM-dependent endosomal trafficking1R21AG066090-01 | ZHAO, ZHEN | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $247,500 | ZRG1 |
| 2019 | Decoding Early Signs of Alzheimer's Disease in The Lateral Entorhinal Cortex Using Machine Learning1R21AG066168-01 | HUSSAINI, S. ABID | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $243,000 | CDIN |
| 2019 | Sex hormones, inflammation, and cognitive decline in older men and women1R21AG066140-01 | KNIGHT, ERIK L | PENNSYLVANIA STATE UNIVERSITY, THE, PA | $239,790 | ZRG1 |
| 2019 | Gene co-expression underlying the connectomic alterations in Alzheimer's disease1R21AG066135-01 | YAN, JINGWEN | INDIANA UNIVERSITY INDIANAPOLIS, IN | $194,366 | MNG |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.